4.3 Article

Changing Etiological Trends in Male Precocious Puberty: Evaluation of 100 Cases with Central Precocious Puberty over the Last Decade

Journal

HORMONE RESEARCH IN PAEDIATRICS
Volume 83, Issue 5, Pages 340-344

Publisher

KARGER
DOI: 10.1159/000377678

Keywords

Central precocious puberty; Males; Etiological factors

Ask authors/readers for more resources

Background/ Aims: There are few studies in the literature that have evaluated the etiological factors in boys with central precocious puberty (CPP), and these studies are limited in terms of the sample size. In the present study, we aimed to evaluate the etiological factors in male CPP cases. Methods: One hundred male CPP subjects, aged between 9 months and 10.5 years, were included. The medical records were screened, and age at diagnosis, bone age, body weight, height, pubertal stage, imaging findings of the pituitary gland, testosterone, and basal and stimulated gonadotropin levels were recorded. Results: There was no underlying cause in 74% of the cases, and an organic cause was determined in only 26%. Most of the organic cases had been diagnosed before the age of 7 years, whereas most of the idiopathic cases had been diagnosed after the age of 7 years. Conclusion: An organic cause was determined in 26% of the male patients with CPP. This rate is one of the lowest rates in the literature and indicates that the number of idiopathic male CPP cases is increasing over time. When a boy is diagnosed with CPP above the age of 7 years, the odds of detecting an underlying pathology are very low, and these cases are mostly idiopathic. (C) 2015 S. Karger AG, Basel

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Cell Biology

Clinical and laboratory parameters predicting a requirement for the reevaluation of growth hormone status during growth hormone treatment Retesting early in the course of GH treatment

Dogus Vuralli, E. Nazli Gonc, Z. Alev Ozon, Ayfer Alikasifoglu, Nurgun Kandemir

GROWTH HORMONE & IGF RESEARCH (2017)

Article Endocrinology & Metabolism

Systemic Pseudohypoaldosteronism Type 1 due to 3 Novel Mutations in SCNN1A and SCNN1B Genes

Atilla Cayir, Yasar Demirelli, Duran Yildiz, Hasan Kahveci, Oguzhan Yarali, Erdal Kurnaz, Dogus Vuralli, Huseyin Demirbilek

HORMONE RESEARCH IN PAEDIATRICS (2019)

Review Biochemistry & Molecular Biology

Ion Transporters, Channelopathies, and Glucose Disorders

Huseyin Demirbilek, Sonya Galcheva, Dogus Vuralli, Sara Al-Khawaga, Khalid Hussain

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)

Article Endocrinology & Metabolism

Treatment with Depot Leuprolide Acetate in Girls with Idiopathic Precocious Puberty: What Parameter should be Used in Deciding on the Initial Dose?

Dogus Vuralli, Ayfer Alikasifoglu, Irem Iyigun, Dicle Canoruc, Alev Ozon, Nazli Gonc, Nurgun Kandemir

JOURNAL OF CLINICAL RESEARCH IN PEDIATRIC ENDOCRINOLOGY (2020)

Article Endocrinology & Metabolism

Central nervous system imaging in girls with central precocious puberty: when is necessary?

Dogus Vuralli, E. Nazli Gonc, Ayfer Alikasifoglu, Nurgun Kandemir, Z. Alev Ozon

ARCHIVES OF ENDOCRINOLOGY METABOLISM (2020)

Review Rheumatology

Kawasaki-like disease in children with COVID-19

Ummusen Kaya Akca, Selman Kesici, Yasemin Ozsurekci, Hayrettin Hakan Aykan, Ezgi Deniz Batu, Erdal Atalay, Selcan Demir, Erdal Sag, Dogus Vuralli, Benan Bayrakci, Yelda Bilginer, Seza Ozen

RHEUMATOLOGY INTERNATIONAL (2020)

Article Genetics & Heredity

Hyperinsulinemic Hypoglycemia in a Patient with Costello Syndrome: An Etiology to Consider in Hypoglycemia

Dogus Vuralli, Can Kosukcu, Ekim Taskiran, Pelin Ozlem Simsek-Kiper, Gulen Eda Utine, Koray Boduroglu, Ayfer Alikasifoglu, Mehmet Alikasifoglu

MOLECULAR SYNDROMOLOGY (2020)

Article Endocrinology & Metabolism

Which parameters predict the beneficial effect of GnRHa treatment on height in girls with central precocious puberty?

Dogus Vuralli, Nazli E. Gonc, Zeynep Alev Ozon, Nurgun Kandemir, Ayfer Alikasifoglu

Summary: The study aimed to determine which girls with idiopathic CPP (iCPP) will benefit from GnRHa treatment in terms of height gain. The most important factor influencing height gain was the chronological age (CA) at treatment onset. Girls treated before 6.4 years of age showed significant height gain, while those treated after 8.3 years did not reach the target. Advanced bone age (BA), basal estradiol (E-2), and pubertal stage were significant factors affecting height gain in girls treated between 6.4 and 8.3 years, with all cases meeting certain criteria showing significant height gain.

CLINICAL ENDOCRINOLOGY (2021)

Review Endocrinology & Metabolism

Managing Severe Hypoglycaemia in Patients with Diabetes: Current Challenges and Emerging Therapies

Huseyin Demirbilek, Dogus Vuralli, Basma Haris, Khalid Hussain

Summary: Hypoglycaemia in diabetic patients is a common problem due to the imbalance between food intake and insulin injections. Improved insulin analogues and novel formulations of glucagon have helped in reducing and preventing hypoglycaemia. However, access to these technologies remains a challenge for many patients.

DIABETES METABOLIC SYNDROME AND OBESITY (2023)

Article Endocrinology & Metabolism

Serum kisspeptin, neurokinin B and inhibin B levels can be used as alternative parameters to distinguish idiopathic CPP from premature thelarche in the early stages of puberty

Dogus Vuralli, Nurdan Ciftci, Huseyin Demirbilek

Summary: This study aims to evaluate the serum levels of kisspeptin, neurokinin-B (NKB), anti-Mullerian hormone (AMH) and inhibin B (INHB) in girls with central precocious puberty (CPP) and assess their diagnostic validity. The results showed that serum levels of kisspeptin, NKB, and INHB were higher, while AMH levels were lower in girls with CPP compared to those with premature thelarche (PT) and prepubertal controls. These findings suggest that these peptides could be used as alternative parameters to distinguish CPP from PT.

CLINICAL ENDOCRINOLOGY (2023)

Review Pediatrics

Clinical Approach to Hypocalcemia in Newborn Period and Infancy: Who Should Be Treated?

Dogus Vuralli

INTERNATIONAL JOURNAL OF PEDIATRICS (2019)

No Data Available